Feature stories
Novartis Vaccines Launches New Online Ordering Site
To better meet the needs of its customers across the US, Novartis Vaccines has recently re-launched its online ordering site, NovartisVaccinesDirect.com. The new site greatly simplifies the purchasing process, allowing healthcare providers to quickly and easily order Novartis vaccines, and have immediate access to their transaction history, product information, and directions for storage and handling.
Read the story (for U.S. residents only)
Seasonal Influenza is more than just a mild cold
Despite the severity of the illness, many people mistakenly believe that influenza is merely a severe cold. While colds and influenza share many symptoms, they are caused by different viruses and can result in different consequences for patients.
Invasive meningococcal disease
According to the World Health Organization, N. meningitidis causes about 500,000 cases of disease and 50,000 deaths worldwide annually. Infants and adolescents have the highest rate of disease, with the highest attack rates in infants three to 12 months old.
Read more about the invasive meningococcal disease
Flu cell culture technology
Cell culture-derived influenza vaccine technology (“flu cell culture”) is an innovative production process for the manufacturing of flu vaccine on the basis of cell cultures.
Read more about the flu cell culture technology
Our Pipeline
Our vaccines development pipeline includes new strategies to protect against flu and meningitis.
Business Development & Licensing
Finding new partnership to develop new vaccines is one of the BD&L team mission.